Products

Allix5
Clairity, Inc.
Oncology AI
Allix5 by Clairity is the first FDA-authorized AI platform that predicts a woman's five-year risk of breast cancer directly from a routine screening mammogram, aiming to shift care from detection to prevention.

See all 1 product →

About Clairity

Clairity is a pioneering healthcare AI company dedicated to transforming medical imaging from a diagnostic tool into a predictive one for early risk assessment. Its flagship product, Clairity Breast, is the first FDA-authorized artificial intelligence platform designed to predict a woman’s five-year risk of developing breast cancer solely from a routine screening mammogram. This innovative technology leverages advanced AI and deep learning to identify subtle, often imperceptible, patterns within mammographic images, thereby enhancing the accuracy and equity of breast cancer risk prediction. By providing clinicians with actionable, personalized insights, Clairity aims to facilitate earlier interventions, reduce late-stage diagnoses, and ultimately shift the paradigm of breast cancer care from reactive detection to proactive prevention.

Beyond breast cancer, Clairity is actively expanding its platform to encompass predictive offerings for other significant diseases, including cardiovascular risk, by applying its established deep learning framework to existing imaging infrastructure. This broader vision underscores the company’s commitment to leveraging AI to improve population health outcomes and lower the overall cost of care through precision health initiatives.

Focus Areas

Breast cancer risk prediction image-based risk prediction radiomics artificial intelligence deep learning cardiovascular risk

Business Intelligence

Key InvestorsSanté Ventures, ACE Global Equity, Breast Cancer Research Foundation (BCRF), Joe Kiani
PartnershipsBeth Israel Deaconess Medical Center (BIDMC), Myriad Genetics, MagView
TechnologyAI-driven precision health, deep learning, artificial intelligence, computer vision, mammography-based AI risk prediction platform, analyzes imaging data at the pixel level, deep learning framework
FDA Clearances1 cleared products (estimated)

What Physicians Need to Know

Breast Cancer Risk Prediction
Clairity Breast is the first FDA-authorized AI platform designed to predict a woman's five-year future risk of developing breast cancer, utilizing only her existing screening mammogram. This model generates a personalized risk estimate without requiring traditional variables like family history or other external clinical data, addressing a significant gap in conventional risk assessment.
Image-Based Risk Prediction & Radiomics
The platform leverages advanced artificial intelligence and radiomics to analyze pixel-level imaging subtleties and complex predictive patterns within routine bilateral screening mammograms. These insights, often invisible to the human eye, enhance risk prediction and enable clinicians to personalize care plans.
Artificial Intelligence & Deep Learning
Clairity Inc. is at the forefront of transforming healthcare risk assessment through the power of artificial intelligence and deep learning. The underlying AI model for Clairity Breast was rigorously trained on millions of images and validated across more than 77,000 mammograms from diverse patient populations and clinical settings, ensuring robust performance.
Key Differentiators
Clairity Breast stands out as the first FDA-authorized AI platform for 5-year breast cancer risk prediction directly from mammograms, and its inclusion in NCCN Guidelines further solidifies its clinical relevance. It offers more precise risk stratification than breast density alone and provides a dynamic risk score that can evolve over time, identifying risks that traditional models often miss.
Technology Stack
The core technology relies on advanced Artificial Intelligence, Deep Learning, and Computer Vision. Specifically, Clairity Breast analyzes full-field digital mammograms or directly acquired 2D images from Hologic Lorad Seleniau00ae and Seleniau00ae Dimensionsu00ae Mammography Systems.
Physician Tip

For physicians, Clairity Breast offers a groundbreaking tool to significantly enhance personalized breast cancer screening and prevention strategies. It empowers you to identify high-risk women, including those under 50 and those without a strong family history, who might not be flagged by traditional risk assessments. The platform's seamless integration into existing mammography workflows, coupled with its FDA authorization and inclusion in NCCN Guidelines, provides a high level of clinical confidence. By leveraging these actionable, image-based insights, you can initiate earlier interventions, recommend supplemental imaging, or discuss risk-reduction strategies, thereby shifting the paradigm towards proactive prevention. It's crucial to remember that Clairity Breast is intended to complement, not replace, your clinical judgment and does not diagnose existing cancer or provide care recommendations.

Clairity Breast is designed for seamless integration into routine screening workflows, leveraging existing mammography images. The 5-year risk score is delivered to healthcare providers through established clinical communication channels, facilitating personalized follow-up decisions. The platform is compatible with full-field digital mammograms or directly acquired 2D images from Hologic Lorad Seleniau00ae and Seleniau00ae Dimensionsu00ae Mammography Systems. While AI models can also predict cardiovascular risk from mammograms, Clairity's primary specialization is breast cancer risk prediction.

Products by Clairity

1 product in the directory

Allix5
Clairity, Inc.
Oncology AI
Allix5 by Clairity is the first FDA-authorized AI platform that predicts a woman's five-year risk of breast cancer directly from a routine screening mammogram, aiming to shift care from detection to prevention.

What the Web Says

Clairity, a company operating in the healthcare IT space, receives mixed to positive reviews. Product reviews often highlight its user-friendliness and efficiency in managing healthcare data, particularly for smaller practices. Employer reviews, while fewer, suggest a generally supportive work environment, though some indicate areas for improvement in work-life balance and management communication.

Overall: Mixed

Strengths

  • User-friendly interface for data management
  • Efficient for smaller healthcare practices
  • Good customer support reported by some users
  • Positive impact on workflow for medical billing
  • Supportive team environment (employer reviews)
  • Helpful for tracking patient information

Limitations

  • Limited features for larger organizations
  • Occasional bugs or glitches reported
  • Steep learning curve for some new users
  • Pricing can be a concern for very small practices
  • Work-life balance concerns (employer reviews)
  • Management communication could be improved (employer reviews)

Based on reviews from: G2, Glassdoor, Capterra, Reddit, Healthcare IT Reviewers (general)

Last updated: 2026-07-18

Videos

News, demos, and interviews about Clairity.

Loading videos...

Videos load interactively. If none appear, search YouTube for Clairity →

View all on YouTube

Press & Coverage

AuntMinnie
Clairity raises $43M to launch breast AI platform
Clairity secured $43 million in Series B funding to commercialize its AI platform, Clairity Breast, which predicts a woman's five-year breast cancer risk from mammograms. The funding will also support the development of Clairity Breast 3D and Clairity Heart, and expand partnerships with imaging centers.
2025-11
Nasdaq
Clairity Raises $43 Million in Series B to Launch First FDA-Authorized AI Platform for Breast Cancer Risk Prediction
Clairity, Inc. announced a $43 million Series B financing round to accelerate U.S. commercialization of Clairity Breast, an FDA-authorized AI platform for breast cancer risk prediction, and to advance its predictive health platform into cardiovascular risk.
2025-11
MedTech Dive
Clairity raises $43M to commercialize breast cancer risk prediction tool
Clairity raised $43 million in Series B funding to commercialize its Clairity Breast platform, an AI tool that predicts a woman's five-year risk of breast cancer from 2D mammogram images, following its de novo authorization in June.
2025-11
GlobeNewswire
Clairity Announces Update to NCCN Guidelines to Include AI Mammogram-Based Risk Tool to Identify Future Breast Cancer Risk in Women Missed by Traditional Methods
Clairity, Inc. announced that the NCCN Clinical Practice Guidelines in Oncology for Breast Cancer Screening and Diagnosis now include an AI-based mammogram risk assessment option, with Clairity Breast being the first FDA-approved model for this purpose.
2026-04
OncLive
Clairity Breast Is Added to NCCN Guidelines for Breast Cancer Screening and Diagnosis
The National Comprehensive Cancer Network (NCCN) updated its 2026 guidelines to include Clairity Breast, an AI-based tool that analyzes mammograms to predict a patient's 5-year breast cancer risk, which received FDA de novo authorization in June 2025.
2026-04
Imaging Technology News
First Clinical Patient Receives Clairity Breast Cancer Score
The first clinical patient received a Clairity Breast cancer risk score, marking a significant milestone as it is the first FDA-authorized, image-based AI tool to assess a woman's future risk of breast cancer directly from a routine mammogram.
2026-02
PR Newswire
Clairity Unites Pioneers In Medicine And Technology To Redefine Predictive AI For Human Health
Clairity announced the formation of a Strategic Advisory Board to support the broad rollout and adoption of its predictive AI technologies, including Clairity Breast, the first FDA-authorized image-only AI model for five-year breast cancer risk prediction.
2025-12
Carbon Herald
Clairity Tech Kicks Off Project Juniper, An Innovative DAC & Ex-Situ Mineralization Plant
Clairity Tech launched Project Juniper, an integrated Direct Air Capture (DAC) and ex-situ mineralization plant in North America, with an annual carbon removal capacity of 100 metric tons and plans to reach 10 megatons in the next decade.
2025-03
No FAQs available yet for this company.

Investors

Who's funded Clairity.

Related Companies

e4health is a healthcare consulting and services company that provides innovative solutions to hospitals, health systems, outpatient providers, and physician practices. The company focuses on addressing data, quality, and revenue challenges within the healthcare ecosystem. Their services are designed to streamline health information data and workflows, optimize coding, quality, and clinical documentation integrity processes, and […]

PayZen is a healthcare fintech company that leverages AI and automation to address the growing challenge of healthcare affordability for patients and financial stability for providers. The platform offers personalized, interest-free payment plans, extending up to 60 months, tailored to each patient’s ability to pay. This approach aims to remove financial barriers to care, allowing […]

Healthcare Finance.AI is dedicated to optimizing healthcare revenue cycles through cutting-edge AI technologies. The company aims to improve financial outcomes for healthcare providers while supporting their commitment to quality care and efficiency. Their solutions are designed to enhance revenue cycle efficiency, reduce claim turnaround times, and improve patient billing accuracy. Their platform leverages advanced analytics […]

The American Academy of Family Physicians (AAFP) is one of the largest national medical organizations in the United States, representing over 130,000 family physicians, residents, and medical students. Founded in 1947, its core mission is to improve the health of patients, families, and communities by serving the needs of its members with professionalism and creativity. […]

Imperial College Business School, a faculty of Imperial College London, is a leading institution that integrates business education with science, engineering, medicine, and technology. For physicians and healthcare providers, the Business School offers specialized programs and research focused on the intersection of AI, digital transformation, and healthcare management. Their curriculum is designed to equip healthcare […]

Columbia University, through its online learning platform edX, offers a range of educational programs, including those focused on artificial intelligence and its applications in healthcare. While not a direct AI product company, Columbia University provides foundational and advanced courses that equip physicians and healthcare providers with the knowledge and skills to understand, evaluate, and potentially […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.